CORPUS CHRISTI, Texas — The makers of an injectable Alzheimer's drug say that in a trial run, it significantly slowed cognitive and functional decline.
Researchers at the University of Colorado Anschutz (CU-Anschutz) have been developing the drug for use in Alzheimer's patients, called Leukine. Leukine is already widely used to help the body make more white blood cells and decrease chances for an infection.
Hundreds of drugs have been tested for the disease, and so far, all have failed, according to the Alzheimer's Association. This one, however, shows some promise in fighting the disease.
Dr. Salim Surani said the path to finding a drug that works has been challenging.
"This is one of the first drugs that has effectively shown it slowed the progression of the disease," Surani said.
The drug slowed the disease progression by 26 percent during the trial, Surani said.
There's still no cure for Alzheimer's disease, but treatments like this can bring hope to many of our seniors suffering from the condition.
Watch the full interview with Surani in the above video player.
More from 3News on KIIITV.com:
- From Texas, with love: Here's how you can help those affected by Hurricane Ian
- Are CC business' COVID relief grants legitimate? Better Business Bureau weighs in
- Her girlfriend was killed and she was left for dead in a brutal attack at a Texas park. A new documentary outlines the story of her recovery.
- Happy 170th Birthday, Corpus Christi!
- Airport now going after Orlando and Las Vegas
Want to send us a news tip?
Put your name and contact information below so we can get in touch with you about your story should we have questions or need more information. We realize some stories are sensitive in nature. Let us know if you'd like to remain anonymous.
If you do not have a photo/video to submit, just click "OK" to skip that prompt.